Publicaciones en las que colabora con JOSÉ TORMO IGUACEL (75)

2012

  1. A yeast-based in vivo bioassay to screen for class i phosphatidylinositol 3-kinase specific inhibitors

    Journal of Biomolecular Screening, Vol. 17, Núm. 8, pp. 1018-1029

2009

  1. Bacterial diversity from benthic mats of Antarctic lakes as a source of new bioactive metabolites

    Marine Genomics, Vol. 2, Núm. 1, pp. 33-41

  2. Discovery of the parnafungins, antifungal metabolites that inhibit mRNA polyadenylation, from the Fusarium larvarum complex and other Hypocrealean fungi

    Mycologia, Vol. 101, Núm. 4, pp. 449-472

  3. Distribution of the antifungal agents sordarins across filamentous fungi

    Mycological Research, Vol. 113, Núm. 6-7, pp. 754-770

2008

  1. Automation of Sample Dispensing Using Pocket Tips for Evaluation of CYP2C9 Isoenzyme Reversible Inhibition in an Evolution Precision Pipetting Platform

    Journal of Laboratory Automation, Vol. 13, Núm. 5, pp. 289-296

  2. Enhancement of antibiotic and secondary metabolite detection from filamentous fungi by growth on nutritional arrays

    Journal of Applied Microbiology, Vol. 104, Núm. 6, pp. 1644-1658

2007

  1. New antitumoral acetogenin 'Guanacone type' derivatives: Isolation and bioactivity. Molecular dynamics simulation of diacetyl-guanacone

    Bioorganic and Medicinal Chemistry, Vol. 15, Núm. 13, pp. 4369-4381

2006

  1. Discovery of FabH/FabF inhibitors from natural products

    Antimicrobial Agents and Chemotherapy, Vol. 50, Núm. 2, pp. 519-526

  2. Discovery of bacterial fatty acid synthase inhibitors from a Phoma species as antimicrobial agents using a new antisense-based strategy

    Journal of Natural Products, Vol. 69, Núm. 3, pp. 377-380

  3. Guanaconetins, new antitumoral acetogenins, mitochondrial complex I and tumor cell growth inhibitors

    Bioorganic and Medicinal Chemistry, Vol. 14, Núm. 4, pp. 1089-1094

  4. Platensimycin is a selective FabF inhibitor with potent antibiotic properties

    Nature, Vol. 441, Núm. 7091, pp. 358-361

  5. Studies on Morinia: Recognition of Morinia longiappendiculata sp. nov. as a new endophytic fungus, and a new circumscription of Morinia pestalozzioides

    Mycologia, Vol. 98, Núm. 4, pp. 616-627

  6. The crystal structure of H-2Db complexed with a partial peptide epitope suggests a major histocompatibility complex class I assembly intermediate

    Journal of Biological Chemistry, Vol. 281, Núm. 18, pp. 12699-12704

  7. The discovery of moriniafungin, a novel sordarin derivative produced by Morinia pestalozzioides

    Bioorganic and Medicinal Chemistry, Vol. 14, Núm. 2, pp. 560-566

2005

  1. Automated analyses of HPLC profiles of microbial extracts a new tool for drug discovery screening

    Natural Products: Drug Discovery and Therapeutic Medicine (Humana Press), pp. 57-75

  2. In vitro antitumor structure-activity relationships of threo/trans/threo/ trans/erythro bis-Tetrahydrofuranic acetogenins: Correlations with their inhibition of mitochondrial complex I

    Oncology Research, Vol. 15, Núm. 3, pp. 129-138

2003

  1. A method for the selection of production media for actinomycete strains based on their metabolite HPLC profiles

    Journal of Industrial Microbiology and Biotechnology, Vol. 30, Núm. 10, pp. 582-588

  2. HPLC studio: A novel software utility to perform HPLC chromatogram comparison for screening purposes

    Journal of Biomolecular Screening, Vol. 8, Núm. 3, pp. 305-315

  3. In Vitro Antitumor Structure-Activity Relationships of threo/trans/threo mono-Tetrahydrofuranic Acetogenins: Correlations with Their Inhibition of Mitochondrial Complex I

    Oncology Research, Vol. 14, Núm. 3, pp. 147-154

  4. Inhibitory effects on mitochondrial complex I of semisynthetic mono-tetrahydrofuran acetogenin derivatives

    Bioorganic and Medicinal Chemistry Letters, Vol. 13, Núm. 22, pp. 4101-4105